Lauri Lehtimäki

Medicine & Life Sciences

1. 3-(2-(4-azidobenzamidino)ethyl)-5-hydroxyindole 6%
2. Adrenal Cortex Hormones 19%
3. Air 5%
4. anti-IgE antibodies 7%
5. Asthma 100%
6. Biological Products 11%
7. Biological Therapy 10%
8. Bronchoconstriction 9%
9. Bronchodilator Agents 9%
10. Child 6%
11. Chronic Obstructive Pulmonary Disease 6%
12. Complement Factor D 5%
13. Cone-Beam Computed Tomography 8%
14. Cross-Sectional Studies 5%
15. Datasets 7%
16. Denmark 5%
17. Dust 8%
18. Dyspnea 10%
19. Eosinophils 9%
20. Exercise 7%
21. Exhalation 5%
22. Finland 27%
23. Guidelines 7%
24. Humidity 5%
25. Inhalation Spacers 6%
26. Interleukin-5 7%
27. Lung 7%
28. Multiple Chemical Sensitivity 7%
29. Nasal Polyps 9%
30. Nitric Oxide 20%
31. Nose 6%
32. Occupational Groups 5%
33. Peanut Hypersensitivity 5%
34. Pollen 6%
35. Population 9%
36. Preschool Children 12%
37. Registries 15%
38. Respiratory Insufficiency 6%
39. Respiratory Sounds 8%
40. Respiratory System 6%
41. SARS Virus 9%
42. Scandinavian and Nordic Countries 8%
43. Steroids 8%
44. Sweden 6%
45. Systematic Reviews 5%
46. Valsartan 5%
47. Workplace 13%